As a result, the proliferation of EGFRmut cells depends on expression of MSI2 in vitro and in vivo, and MSI2 depletion enhances the activity of EGFR-targeted inhibitors in EGFRmut NSCLC. Here, MSI2 is linked to non-small cell lung carcinoma.